BOUNDLESS NUTRITION LLC – Trademark Portfolio
Entity Type: 16
BOUNDLESS NUTRITION LLC holds 13 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 30 (Staple Foods) — 9 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include BOUNDLESS NUTRITION. The owner is based in AUSTIN, TX.
4020 S. INDUSTRIAL DR STE 133
AUSTIN, TX 78744
Showing of trademarks Trademarks
Trademark Classifications
BOUNDLESS NUTRITION LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Advertising; business management; business administration; office functions
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does BOUNDLESS NUTRITION LLC have?
BOUNDLESS NUTRITION LLC has 13 U.S. trademarks filed with the USPTO. Of these, 1 registered, 7 abandoned, 5 cancelled.
What trademark classes does BOUNDLESS NUTRITION LLC file in?
BOUNDLESS NUTRITION LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 30 (Staple Foods), Class 35 (Advertising & Business), Class 5 (Pharmaceuticals). Class 30 covers coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations.
What are BOUNDLESS NUTRITION LLC's most well-known trademarks?
BOUNDLESS NUTRITION LLC's registered trademark portfolio includes well-known marks such as BOUNDLESS NUTRITION. These are among 1 currently registered trademark in the portfolio.
What is BOUNDLESS NUTRITION LLC's trademark registration success rate?
BOUNDLESS NUTRITION LLC has a 8% trademark registration rate, with 1 out of 13 resolved applications resulting in successful registration. Currently, 0 applications are pending review.